nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—DRD5—attention deficit hyperactivity disorder	0.173	0.221	CbGaD
Dopamine—COMT—attention deficit hyperactivity disorder	0.109	0.14	CbGaD
Dopamine—DRD4—attention deficit hyperactivity disorder	0.0885	0.113	CbGaD
Dopamine—MAOA—attention deficit hyperactivity disorder	0.0824	0.105	CbGaD
Dopamine—DRD3—attention deficit hyperactivity disorder	0.0763	0.0977	CbGaD
Dopamine—DRD1—attention deficit hyperactivity disorder	0.0749	0.0959	CbGaD
Dopamine—SLC6A3—attention deficit hyperactivity disorder	0.071	0.0909	CbGaD
Dopamine—SLC6A4—attention deficit hyperactivity disorder	0.0531	0.068	CbGaD
Dopamine—DRD2—attention deficit hyperactivity disorder	0.0528	0.0676	CbGaD
Dopamine—DBH—locus ceruleus—attention deficit hyperactivity disorder	0.0106	0.147	CbGeAlD
Dopamine—DBH—autonomic nervous system—attention deficit hyperactivity disorder	0.00564	0.0784	CbGeAlD
Dopamine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00404	0.0562	CbGeAlD
Dopamine—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.0039	0.0541	CbGeAlD
Dopamine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.00373	0.0518	CbGeAlD
Dopamine—POU5F1—cerebellum—attention deficit hyperactivity disorder	0.00355	0.0492	CbGeAlD
Dopamine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00215	0.0298	CbGeAlD
Dopamine—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00207	0.0288	CbGeAlD
Dopamine—DBH—forebrain—attention deficit hyperactivity disorder	0.00131	0.0183	CbGeAlD
Dopamine—DRD5—forebrain—attention deficit hyperactivity disorder	0.00101	0.014	CbGeAlD
Dopamine—DRD1—forebrain—attention deficit hyperactivity disorder	0.000772	0.0107	CbGeAlD
Dopamine—Levonordefrin—ADRA2C—attention deficit hyperactivity disorder	0.000724	0.126	CrCbGaD
Dopamine—DBH—nervous system—attention deficit hyperactivity disorder	0.000714	0.00992	CbGeAlD
Dopamine—COMT—forebrain—attention deficit hyperactivity disorder	0.000695	0.00966	CbGeAlD
Dopamine—DBH—central nervous system—attention deficit hyperactivity disorder	0.000687	0.00955	CbGeAlD
Dopamine—DBH—cerebellum—attention deficit hyperactivity disorder	0.000672	0.00933	CbGeAlD
Dopamine—DRD4—brain—attention deficit hyperactivity disorder	0.000637	0.00884	CbGeAlD
Dopamine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.000621	0.00862	CbGeAlD
Dopamine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000611	0.00849	CbGeAlD
Dopamine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.000589	0.00818	CbGeAlD
Dopamine—COMT—cardiovascular system—attention deficit hyperactivity disorder	0.000588	0.00816	CbGeAlD
Dopamine—DRD3—nervous system—attention deficit hyperactivity disorder	0.000586	0.00813	CbGeAlD
Dopamine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000569	0.0079	CbGeAlD
Dopamine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000564	0.00783	CbGeAlD
Dopamine—DRD5—nervous system—attention deficit hyperactivity disorder	0.000549	0.00762	CbGeAlD
Dopamine—Dobutamine—COMT—attention deficit hyperactivity disorder	0.000547	0.0954	CrCbGaD
Dopamine—Methyldopa—COMT—attention deficit hyperactivity disorder	0.000547	0.0954	CrCbGaD
Dopamine—DBH—brain—attention deficit hyperactivity disorder	0.000546	0.00758	CbGeAlD
Dopamine—MAOB—forebrain—attention deficit hyperactivity disorder	0.000541	0.00751	CbGeAlD
Dopamine—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000528	0.00734	CbGeAlD
Dopamine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00051	0.00708	CbGeAlD
Dopamine—Droxidopa—ADRA2C—attention deficit hyperactivity disorder	0.00051	0.0889	CrCbGaD
Dopamine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000505	0.00702	CbGeAlD
Dopamine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000501	0.00696	CbGeAlD
Dopamine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000498	0.00692	CbGeAlD
Dopamine—HTR7—forebrain—attention deficit hyperactivity disorder	0.000483	0.0067	CbGeAlD
Dopamine—MAOA—forebrain—attention deficit hyperactivity disorder	0.000461	0.00641	CbGeAlD
Dopamine—COMT—midbrain—attention deficit hyperactivity disorder	0.000459	0.00638	CbGeAlD
Dopamine—MAOB—cardiovascular system—attention deficit hyperactivity disorder	0.000457	0.00635	CbGeAlD
Dopamine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000456	0.00634	CbGeAlD
Dopamine—L-DOPA—DRD5—attention deficit hyperactivity disorder	0.000455	0.0794	CrCbGaD
Dopamine—DRD3—brain—attention deficit hyperactivity disorder	0.000448	0.00622	CbGeAlD
Dopamine—Norepinephrine—ADRA2C—attention deficit hyperactivity disorder	0.000429	0.0749	CrCbGaD
Dopamine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000427	0.00593	CbGeAlD
Dopamine—DRD5—brain—attention deficit hyperactivity disorder	0.000419	0.00583	CbGeAlD
Dopamine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000419	0.00582	CbGeAlD
Dopamine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00041	0.00569	CbGeAlD
Dopamine—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000408	0.00567	CbGeAlD
Dopamine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000404	0.00561	CbGeAlD
Dopamine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.00039	0.00542	CbGeAlD
Dopamine—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.000389	0.0679	CrCbGaD
Dopamine—COMT—nervous system—attention deficit hyperactivity disorder	0.000377	0.00524	CbGeAlD
Dopamine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000376	0.00522	CbGeAlD
Dopamine—COMT—central nervous system—attention deficit hyperactivity disorder	0.000363	0.00505	CbGeAlD
Dopamine—MAOB—midbrain—attention deficit hyperactivity disorder	0.000357	0.00496	CbGeAlD
Dopamine—COMT—cerebellum—attention deficit hyperactivity disorder	0.000355	0.00493	CbGeAlD
Dopamine—Methyldopa—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.0608	CrCbGaD
Dopamine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000337	0.00468	CbGeAlD
Dopamine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000334	0.00463	CbGeAlD
Dopamine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000332	0.00461	CbGeAlD
Dopamine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000324	0.00451	CbGeAlD
Dopamine—DRD1—brain—attention deficit hyperactivity disorder	0.000321	0.00445	CbGeAlD
Dopamine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.00032	0.00444	CbGeAlD
Dopamine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.00032	0.00444	CbGeAlD
Dopamine—HTR7—midbrain—attention deficit hyperactivity disorder	0.000319	0.00443	CbGeAlD
Dopamine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000317	0.00441	CbGeAlD
Dopamine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000317	0.0044	CbGeAlD
Dopamine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000309	0.00429	CbGeAlD
Dopamine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000309	0.00429	CbGeAlD
Dopamine—Levonordefrin—ADRA2A—attention deficit hyperactivity disorder	0.000309	0.0539	CrCbGaD
Dopamine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000308	0.00427	CbGeAlD
Dopamine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.000305	0.00424	CbGeAlD
Dopamine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000305	0.00423	CbGeAlD
Dopamine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000301	0.00419	CbGeAlD
Dopamine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000297	0.00413	CbGeAlD
Dopamine—MAOB—nervous system—attention deficit hyperactivity disorder	0.000294	0.00408	CbGeAlD
Dopamine—COMT—brain—attention deficit hyperactivity disorder	0.000288	0.00401	CbGeAlD
Dopamine—MAOB—central nervous system—attention deficit hyperactivity disorder	0.000283	0.00393	CbGeAlD
Dopamine—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.000281	0.0039	CbGeAlD
Dopamine—MAOB—cerebellum—attention deficit hyperactivity disorder	0.000276	0.00384	CbGeAlD
Dopamine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000274	0.00381	CbGeAlD
Dopamine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000274	0.00381	CbGeAlD
Dopamine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000272	0.00378	CbGeAlD
Dopamine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000264	0.00367	CbGeAlD
Dopamine—HTR7—nervous system—attention deficit hyperactivity disorder	0.000262	0.00364	CbGeAlD
Dopamine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000262	0.00364	CbGeAlD
Dopamine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000258	0.00358	CbGeAlD
Dopamine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000258	0.00358	CbGeAlD
Dopamine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000254	0.00352	CbGeAlD
Dopamine—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000252	0.0035	CbGeAlD
Dopamine—MAOA—nervous system—attention deficit hyperactivity disorder	0.00025	0.00348	CbGeAlD
Dopamine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000248	0.00344	CbGeAlD
Dopamine—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000247	0.00342	CbGeAlD
Dopamine—ADRB1—brain—attention deficit hyperactivity disorder	0.000244	0.00339	CbGeAlD
Dopamine—SLC22A3—brain—attention deficit hyperactivity disorder	0.000242	0.00337	CbGeAlD
Dopamine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000241	0.00335	CbGeAlD
Dopamine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000239	0.00331	CbGeAlD
Dopamine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000236	0.00328	CbGeAlD
Dopamine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000236	0.00327	CbGeAlD
Dopamine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000233	0.00324	CbGeAlD
Dopamine—L-DOPA—DRD4—attention deficit hyperactivity disorder	0.000233	0.0406	CrCbGaD
Dopamine—MAOB—brain—attention deficit hyperactivity disorder	0.000224	0.00312	CbGeAlD
Dopamine—Droxidopa—ADRA2A—attention deficit hyperactivity disorder	0.000218	0.0379	CrCbGaD
Dopamine—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.000217	0.00302	CbGeAlD
Dopamine—HTR1A—brain—attention deficit hyperactivity disorder	0.00021	0.00291	CbGeAlD
Dopamine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000208	0.00289	CbGeAlD
Dopamine—L-DOPA—DRD3—attention deficit hyperactivity disorder	0.000201	0.035	CrCbGaD
Dopamine—HTR7—brain—attention deficit hyperactivity disorder	0.0002	0.00278	CbGeAlD
Dopamine—L-DOPA—DRD1—attention deficit hyperactivity disorder	0.000197	0.0344	CrCbGaD
Dopamine—MAOA—brain—attention deficit hyperactivity disorder	0.000191	0.00266	CbGeAlD
Dopamine—DRD2—brain—attention deficit hyperactivity disorder	0.000189	0.00263	CbGeAlD
Dopamine—Norepinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000183	0.0319	CrCbGaD
Dopamine—SLC22A5—brain—attention deficit hyperactivity disorder	0.000176	0.00245	CbGeAlD
Dopamine—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.029	CrCbGaD
Dopamine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000149	0.00207	CbGeAlD
Dopamine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000143	0.00199	CbGeAlD
Dopamine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00014	0.00195	CbGeAlD
Dopamine—Norepinephrine—DRD2—attention deficit hyperactivity disorder	0.000139	0.0242	CrCbGaD
Dopamine—L-DOPA—DRD2—attention deficit hyperactivity disorder	0.000139	0.0242	CrCbGaD
Dopamine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000114	0.00158	CbGeAlD
Dopamine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.57e-05	0.000111	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.57e-05	0.000111	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.56e-05	0.000111	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.56e-05	0.00011	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.55e-05	0.00011	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.54e-05	0.000109	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.53e-05	0.000109	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.53e-05	0.000108	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.53e-05	0.000108	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.52e-05	0.000108	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.52e-05	0.000107	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.52e-05	0.000107	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.51e-05	0.000107	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.5e-05	0.000107	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.5e-05	0.000106	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.48e-05	0.000105	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.48e-05	0.000105	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	0.000105	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.47e-05	0.000104	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.47e-05	0.000104	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	1.47e-05	0.000104	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.46e-05	0.000104	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.46e-05	0.000104	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.46e-05	0.000103	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.46e-05	0.000103	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.46e-05	0.000103	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.45e-05	0.000103	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.42e-05	0.000101	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.41e-05	0.0001	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.39e-05	9.88e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.39e-05	9.83e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.39e-05	9.82e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.38e-05	9.79e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.38e-05	9.79e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.38e-05	9.77e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.37e-05	9.74e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.37e-05	9.71e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.36e-05	9.67e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.36e-05	9.66e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.36e-05	9.62e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.35e-05	9.57e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.35e-05	9.57e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.35e-05	9.55e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.35e-05	9.55e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.35e-05	9.54e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.33e-05	9.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.33e-05	9.43e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.33e-05	9.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.33e-05	9.39e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.32e-05	9.39e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.32e-05	9.38e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.32e-05	9.35e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	9.32e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.31e-05	9.31e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—MAOA—attention deficit hyperactivity disorder	1.3e-05	9.18e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.29e-05	9.16e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.29e-05	9.16e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	9.15e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.29e-05	9.13e-05	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	1.28e-05	9.09e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.28e-05	9.08e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	1.28e-05	9.08e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.28e-05	9.08e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.28e-05	9.04e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.27e-05	9.03e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.27e-05	8.98e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	1.26e-05	8.93e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.25e-05	8.89e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.25e-05	8.84e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.24e-05	8.81e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.24e-05	8.78e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—COMT—attention deficit hyperactivity disorder	1.24e-05	8.77e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.23e-05	8.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.23e-05	8.73e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.23e-05	8.7e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.23e-05	8.69e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.21e-05	8.59e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.21e-05	8.58e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.21e-05	8.57e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.2e-05	8.49e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.19e-05	8.46e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.19e-05	8.44e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.19e-05	8.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.17e-05	8.31e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.17e-05	8.3e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.16e-05	8.25e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.16e-05	8.21e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.16e-05	8.21e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.16e-05	8.2e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.15e-05	8.18e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.13e-05	8.04e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	8.04e-05	CbGpPWpGaD
Dopamine—DBH—Metabolism—EP300—attention deficit hyperactivity disorder	1.13e-05	8.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.13e-05	8e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.96e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.94e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	7.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.11e-05	7.89e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.08e-05	7.68e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.08e-05	7.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.08e-05	7.67e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.08e-05	7.65e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.08e-05	7.62e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.07e-05	7.55e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.06e-05	7.49e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.05e-05	7.43e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	1.05e-05	7.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.04e-05	7.38e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.04e-05	7.36e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	7.3e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.03e-05	7.28e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.02e-05	7.26e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.02e-05	7.23e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.02e-05	7.21e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.01e-05	7.17e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.01e-05	7.16e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.01e-05	7.16e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.93e-06	7.04e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.91e-06	7.02e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.82e-06	6.96e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.76e-06	6.92e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.75e-06	6.91e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.68e-06	6.86e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.55e-06	6.77e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.51e-06	6.74e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.4e-06	6.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.36e-06	6.64e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.35e-06	6.63e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.23e-06	6.54e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.23e-06	6.54e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.11e-06	6.45e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.1e-06	6.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.98e-06	6.37e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.96e-06	6.35e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.95e-06	6.34e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.79e-06	6.23e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.78e-06	6.23e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.7e-06	6.17e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.67e-06	6.15e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.66e-06	6.14e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.6e-06	6.1e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.35e-06	5.92e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.32e-06	5.9e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.24e-06	5.84e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.23e-06	5.84e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.2e-06	5.81e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.19e-06	5.8e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.08e-06	5.73e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.07e-06	5.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.06e-06	5.71e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.01e-06	5.68e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.96e-06	5.64e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.95e-06	5.63e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.9e-06	5.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.86e-06	5.57e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.85e-06	5.56e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.83e-06	5.55e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.81e-06	5.54e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	7.76e-06	5.5e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.68e-06	5.45e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.61e-06	5.39e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.56e-06	5.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.41e-06	5.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.37e-06	5.22e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.31e-06	5.18e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.31e-06	5.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.28e-06	5.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.24e-06	5.13e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.15e-06	5.07e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.05e-06	5e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.93e-06	4.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.87e-06	4.87e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.84e-06	4.85e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.84e-06	4.85e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.66e-06	4.72e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.64e-06	4.7e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	6.56e-06	4.65e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.52e-06	4.62e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.39e-06	4.53e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.37e-06	4.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.19e-06	4.39e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	6.12e-06	4.34e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.08e-06	4.31e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.07e-06	4.3e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	6.06e-06	4.3e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.06e-06	4.3e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.03e-06	4.27e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.01e-06	4.26e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	5.96e-06	4.23e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.77e-06	4.09e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—EP300—attention deficit hyperactivity disorder	5.59e-06	3.97e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	5.58e-06	3.95e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.58e-06	3.95e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.55e-06	3.93e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	5.53e-06	3.92e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.53e-06	3.92e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	5.49e-06	3.89e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	5.44e-06	3.85e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—EP300—attention deficit hyperactivity disorder	5.3e-06	3.76e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.19e-06	3.68e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.12e-06	3.63e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.1e-06	3.61e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.06e-06	3.58e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.85e-06	3.44e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.72e-06	3.35e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	4.72e-06	3.35e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.67e-06	3.31e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	4.65e-06	3.29e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.61e-06	3.27e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	4.49e-06	3.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.46e-06	3.16e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.46e-06	3.16e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.42e-06	3.13e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.32e-06	3.06e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.24e-06	3.01e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.21e-06	2.98e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.14e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.92e-06	2.78e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.78e-06	2.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	3.67e-06	2.6e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	3.65e-06	2.58e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.6e-06	2.55e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.54e-06	2.51e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.38e-06	2.39e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.35e-06	2.38e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	3.35e-06	2.37e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	3.33e-06	2.36e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	3.33e-06	2.36e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.23e-06	2.29e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.19e-06	2.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.06e-06	2.17e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.86e-06	2.03e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.84e-06	2.01e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.81e-06	1.99e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.76e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.75e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.71e-06	1.92e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.62e-06	1.86e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.47e-06	1.75e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.37e-06	1.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.08e-06	1.47e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	1.58e-06	1.12e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.45e-06	1.03e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	1.44e-06	1.02e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.23e-06	8.7e-06	CbGpPWpGaD
